ArticleBMC endocrine disorders2025
An interpretable multimodal machine learning model for predicting malignancy of thyroid nodules in low-resource scenarios.
Article in BMC endocrine disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From explainability to clinical actionability: translating artificial intelligence models into decision support for endocrine disease management.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThyroid nodules (TNs) represent a prevalent clinical issue in endocrinology. The diagnostic process for malignant TNs typically involves a three-stage detection: the function detection, color ultrasound (CU) detection and biopsy. Early identification is crucial for effective management of malignant TNs.
methodsThis study developed a multimodal network for classifying CU images and thyroid function (TF) test data. Specifically, the PubMedClIP model was employed to extract visual features from CU images, generating a 512-dimensional feature vector. This vector was subsequently concatenated with five indicators of TF tests, as well as gender and age information, to construct a comprehensive representation. The combined representation was then fed into a downstream ML classifier, where we evaluated seven models, including AdaBoost, Random Forest, and Logistic Regression.
resultsAmong the seven ML models evaluated, the AdaBoost classifier demonstrated the highest overall performance, surpassing other classifiers in terms of area under the curve (AUC), F1, accuracy, and coordinate attention (CA) metrics. The incorporation of visual features extracted from CU images using PubMedCLIP further enhanced the model’s performance. Feature importance analysis revealed that laboratory indicators such as free thyroxine (FT4), free triiodothyronine (FT3), and clip_feature_184 were the most influential clinical variables. Additionally, the integration of PubMedCLIP significantly improved the model’s capacity to accurately classify data by leveraging both clinical and imaging information.
conclusionThe proposed PubMedCLIP-based multimodal framework, which jointly utilizes ultrasound imaging features and clinical laboratory data, demonstrated superior diagnostic performance in differentiating benign from malignant TNs. This approach offers a promising tool for individualized risk assessment and clinical decision support, potentially facilitating more precise and personalized protocols for patients with TNs. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.